Company intelligence / Profile preview

Atticus Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Atticus Capital was a prominent American hedge fund management firm founded in 1995 by Timothy Barakett. At its peak, the firm managed over $20 billion in assets and was known for its aggressive activist investment strategies and significant positions in various global markets. While the firm invested across multiple sectors, it was not a life sciences or biotechnology company and did not maintain a drug development pipeline. Atticus Capital ceased most of its operations and returned capital to investors in 2009 following the global financial crisis.

Industry: Investors

Beyond the preview

Go deeper on Atticus Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atticus Capital.

Explore the full profile